Oscar Muñoz-Aznar

AC-265347 Inhibits Neuroblastoma Tumor Growth by Induction of Differentiation without Causing Hypocalcemia

J. Mora, Marta García, C. Lavarino, 2022, International journal of molecular sciences.

The onset of PI3K‐related vascular malformations occurs during angiogenesis and is prevented by the AKT inhibitor miransertib

J. Mora, B. Javierre, C. Lavarino, 2022, EMBO molecular medicine.

Low dose AKT inhibitor miransertib cures PI3K-related vascular malformations in preclinical models of human disease

J. Mora, C. Lavarino, M. Graupera, 2021, bioRxiv.

Identification of immunosuppressive factors in retinoblastoma cell secretomes and aqueous humor from patients

J. Mora, F. Radvanyi, C. Lavarino, 2022, The Journal of pathology.

Prognostic value of patient‐derived xenograft engraftment in pediatric sarcomas

J. Mora, C. Lavarino, A. Carcaboso, 2021, The journal of pathology. Clinical research.

SPARC-mediated long-term retention of nab-paclitaxel in pediatric sarcomas.

J. Mora, E. de Álava, A. Gómez-Caballero, 2021, Journal of controlled release : official journal of the Controlled Release Society.